Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | +1.00% | +13.85% | -26.81% |
May. 06 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
Apr. 26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
Financials (USD)
Sales 2023 * | 37.41M | Sales 2024 * | 125M | Capitalization | 193M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -236M | EV / Sales 2023 * | -1.28 x |
Net cash position 2023 * | 241M | Net cash position 2024 * | 106M | EV / Sales 2024 * | 0.69 x |
P/E ratio 2023 * |
-0.6
x | P/E ratio 2024 * |
-0.63
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | +1.00% | ||
1 week | +13.85% | ||
Current month | +13.85% | ||
1 month | -12.93% | ||
3 months | +7.94% | ||
6 months | -71.47% | ||
Current year | -26.81% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 0 M€ | -3.93% | ||
0.11% | 0 M€ | +3.48% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 1.01 | +1.00% | 3,507,940 |
24-05-06 | 1 | +11.14% | 20,043,956 |
24-05-03 | 0.8998 | -0.39% | 7,099,031 |
24-05-02 | 0.9033 | -0.66% | 6,864,439 |
24-05-01 | 0.9093 | +2.50% | 8,633,205 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.81% | 193M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- BLUE Stock